Tag: COVID-19
-
![FansUnite Entertainment (FANS.C) offers gaming options to get through the COVID-19 lockdown season]()
FansUnite Entertainment (FANS.C) offers gaming options to get through the COVID-19 lockdown season
I’m getting really tired of this lockdown game. Every year it’s just the same. Ontario, Quebec and California have already closed down essential businesses, and Yonge Street in Toronto is empty enough that it could be a stand-in setting for a post-apocalyptic thriller. So far, BC’s premier, John Horgan, has resisted the lockdown call to…
-
![FansUnite Entertainment (FANS.C) offers gaming options to get through the COVID-19 lockdown season]()
FansUnite Entertainment (FANS.C) offers gaming options to get through the COVID-19 lockdown season
I’m getting really tired of this lockdown game. Every year it’s just the same. Ontario, Quebec and California have already closed down essential businesses, and Yonge Street in Toronto is empty enough that it could be a stand-in setting for a post-apocalyptic thriller. So far, BC’s premier, John Horgan, has resisted the lockdown call to…
-
![Xphyto (XPHY.C) partner/acquisition target achieves major milestone with Covid-19 biosensor candidates]()
Xphyto (XPHY.C) partner/acquisition target achieves major milestone with Covid-19 biosensor candidates
On July 28, 2021 Xphyto Therapeutics (XPHY.C) announced that its acquisition target, 3a-diagnostics GmbH, has identified the first saliva-activated in-mouth biosensor candidates for the detection of a COVID-19 infection. Xphyto Therapeutics is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities. 3a-diagnostics is currently a commercial partner of…
-
![XPhyto Therapeutics (XPHY.C) Signs Acquisition Agreement with 3a-Diagnostics, Enters Biosensor Market]()
XPhyto Therapeutics (XPHY.C) Signs Acquisition Agreement with 3a-Diagnostics, Enters Biosensor Market
XPhyto Therapeutics (XPHY.C) announced today that it has signed a definitive agreement for the acquisition of 3a-Diagnostics GmhB, Frickenhausen, Germany, XPhyto’s exclusive diagnostic development partner. “We have collaborated closely with the 3a-diagnostics team on several diagnostics products and have found them to be a highly innovative and focused partner. The successful development and recent launch…
-
![Revive Therapeutics (RVV.C) incredible patent-portfolio explained]()
Revive Therapeutics (RVV.C) incredible patent-portfolio explained
Revive Therapeutics (RVV.C) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. RVV holds 13 patents (issued and provisional) for covid-treatment, gout, drug delivery systems, cannabidiol and psilocybin. “We are proud of the IP portfolio that we’ve generated,” stated Michael Frank, CEO of Revive…
-
![XPhyto (XPHY.C) partner will begin sale of rapid Covid-ID Lab tests in Germany next week]()
XPhyto (XPHY.C) partner will begin sale of rapid Covid-ID Lab tests in Germany next week
XPhyto Therapeutics (XPHY.C) announced their partner Max Pharma GmbH will begin to sell XPhyto’s rapid point-of-care Covid-19 PCR test system (Covid-ID Lab) in Germany next week. The Covid-ID Lab test provides quality testing for the Covid-19 virus, achieving a 95% confidence interval, and delivering results within 25 minutes. Covid-ID Lab is registered within the European…
-
![Draganfly (DFLY.C) deal with Coldchain Technology Solutions brings vaccine to remote areas]()
Draganfly (DFLY.C) deal with Coldchain Technology Solutions brings vaccine to remote areas
Globally, as of 3:42pm CEST, 13 May 2021, there have been 160,074,267 confirmed cases of COVID-19, including 3,325,260 deaths, reported to WHO. As of 12 May 2021, a total of 1,264,164,553 vaccine doses have been https://equity.guru/wp-content/uploads/2021/10/tnw8sVO3j-2.pngistered. Most of those are in urban centres where the virus is concentrated. Here’s what it looks like locally: It’s…
